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In recent years, Michael F. Oliver has written numerous 
editorials (I). including the accompanying editorial in this 
issue of the Journal (2). concemiog his doubts about the 
wisdom of changing Western diets or administering hypoli- 
pidemic drugs ia an attempt to reduce cardiovascular mor- 
tality. He argues that hypolipidemic regimens in several 
trials had no beneficial influence on total monalily and were 
even associated with excess noncardiovascular mortality. 
However, a closer review of these trials reveals that the 
participating investi@ors failed to arrive at definitive coo- 
elusions. In the Lipid Research Clinics Coronary Primary 
Prevention Trial (3) and the Helsinki Heart Study (4). 
noncardiovascular mortality rates in control groups ap- 
wared to be tutrepresentatively low compared with corre- 
&mnding mortelit; rates in the populatibn at large. It is 
difficult to understand why hypercholesterolemic ontrol 
groups receiving a placebo should fare better than the 
age-matched general population. Therefore, the investiga- 
tars of these two studies (3.4) concluded. correctly we 
believe. that apparent excess noncardiovascular mortality 
was ascribable to chance. 
Oliver has repeatedly expressed his anxieties about re- 
sults of “mass interventions” on nation economies. He is 
concerned about what campaigns against smoking or lipid 
rich diets could do to the tobacco or farming industries. Such 
considerations hardly seem appropriate. It is like saying we 
should not fight drug addiction or alcoholism for fear of 
hurting the ec-nomy of nations that supply drugs and 
alcoholic bevcragcs. In addition, economists with massive 
resources find performing short-term trend analyses difficult. 
Likewise. predicting the long-term worldwide effects of 
gradual changes in dietary habits presents even more of a 
challenge. Moreover. Oliver ought to recognize that the 
hyputherical mass interventions he fears have, in fact, al- 
ready taken place. Governmental statistics indicate that over 
the past 20 years there have been spectacular changes in the 
diets of several nations. In countries where fat consumption 
has increased, such as Japan (5). cardiac mortality has been 
on the rise, whereas in countries where consumption of 
animal fat has decreased. such as the United States (6), 
cardiac mortality has correspondingly declined. 
Interpretntion of previous trials. Unfortunately. ergo- 
mutts formulated by cholesterol essayists are based in part 
on statislical misconceptions and erroneous interpretations 
of previous trials. For instawze, Oliver’s introdcctory state- 
ments are devoted to the Veterans Administration Los 
Angeles Study (7). which he characterizes as being “care- 
fully designed and rigorously conducted.” First, this study 
was not really designed to evaluate effects of a low choles- 
terol, low fat diet because both experimental and control 
groups were maintained on a diet containing 4t% of calories 
as fats. More imporkant, one finds iiiilt the dropout rate in the 
experimental group was twice that of the control group; in 
both groupa there was an inexplicable progressive decrease 
in cholesterolemia over a period of years. although diet and 
body wetit were claimed to be constant. Also. the influence 
of f&d i&ke tetween meals was unknown because only 
standard meals were controlleo. and dietary adherence rate 
inappropriately depended on lixpitalizrdion rate. Smoking 
was neither controlled nor win recorded and may have 
differed significantly between groups. After considering ex- 
cesa lung cancer mortality in the experirxntal group, non- 
cardiovascular mortality may not have been found to differ 
significantly between control and experimental groups. 
These observations raise some doubts about the author’s 
euphemistic characterization ofthe Veterans Administration 
trkd. 
Another study mentioned by Oliver is one by Taylor and 
coworkers (gj, which uses data from the past, namely the 
Framingham data, to pmduce a model supposedly applicable 
to the future. In both the Multiple Risk Factor Intervention 
Trial (9) and the recently published preliminary report on the 
Phvsicians’ Health Studr GO). ore of data from the east hv 
epidemiologists has r&ted in predicted mortality r&s thit 
were grossly 08 target. This should be a warning signal to 
those who attempt to forecast monalily rates. Even more 
disconcerting, however, is that the figures excerpted from the 
Framingham data base and the mathematical model applied 
were in error. Taylor et al. (8) appear to have misinterpreted 
the table published in Monograph 30 of the Franingham 
Study (IIJZ). Also, aspointedout by Frommere: al. (12)and 
Castelli (I I), Taylor et al. erred in their choice of coefficients 
and for use in their simple cwvilinear ew%ion. Usinx correct 
coefficients and sele&g correct d&a. a reanaiysis by 
Frommer sug@sts that Taylor et al. (g) r~ascalculated death 
rates by B factor of4 to 5 (I 1.12). 
Implications. In the context of potential personal and 
collective gains derived from so-called interventions. it 
appears inappro?riatc to ~ICUS solely on death rates because 
patients with coronary anery disease often w&r for many 
years during which they receive costly medical care. The 
economic burden of coronary anery disease is difficult to 
predict, but the contindnE emerzcnce of new diaenostic and 
therapeutic procrdures. S&Y as&al coronary &gioplasty. 
coronary surgery. and the use of very expensive biosyn- 
thetic drugs (fibrinolytic agents). is not completely resssur- 
ing. Oliver’s economic speculations do not extend to rhn 
aspect of the question. 
The virtue of Oliver’s editorials is that they stimulate us 
to critically reassess a: views. However. his knsidemtionc 
would be more convincing if they were based on a balanced 
selection of the litcratore. For example. it may not be 
fortuitous that Dr. Oliver fails to mention the Coronary Drug 
Study (13) that has shown a delayed beneficial effect 011 
mo@ality. Atherosclerosis develops over decades of tbfe 
(t4.15) and imervemiuns cannut be eiipi-i:ed :G ;bow -La: 
would happen if certain Western populations could be cdu- 
cated to develop a taste for low fat diets. Current epidemi- 
ologic. therapeutic, expaimenral and anthropologic evi- 
dence does not support the view the1 high fat regimens 
represent an optimal diet for humans. Oliver should make an 
effort to review overall evidence rather than focus ectecti- 
ally on the ambiguities of compk* I.x~g.term rriais. 
